发明申请
US20030108982A1 Process for oxidation of steroids and genetically engineered cells used therein
审中-公开
用于其中使用的类固醇和基因工程细胞的氧化过程
- 专利标题: Process for oxidation of steroids and genetically engineered cells used therein
- 专利标题(中): 用于其中使用的类固醇和基因工程细胞的氧化过程
-
申请号: US10084814申请日: 2002-02-26
-
公开(公告)号: US20030108982A1公开(公告)日: 2003-06-12
- 发明人: Herman Slijkhuis , Eric Bastiaan Smaal , Gerardus Cornelis Maria Selten
- 申请人: Aventis Pharma S.A.
- 申请人地址: null
- 专利权人: Aventis Pharma S.A.
- 当前专利权人: Aventis Pharma S.A.
- 当前专利权人地址: null
- 优先权: NL88202080.3 19880923; NL88200904.6 19880506; NLPCT/NL89/0072 19890925; NL88202080.3 19880923
- 主分类号: C12P033/08
- IPC分类号: C12P033/08 ; C12N001/21 ; C12N015/74
摘要:
An expression cassette, operable in a recombinant host, comprising a heterologous DNA coding sequence encoding a protein, which is functional, alone or in cooperation with one or more additional proteins, of catalyzing an oxidation step in the biological pathway for conversion of cholesterol into hydrocortisone, which step is selected from the group consisting a of: the conversion of cholesterol to pregnenolone; the conversion of pregnenolone to progesterone; the conversion of progesterone to 17null-hydroxy-progesterone; the conversion of 17null-hydroxyprogesterone to cortexolone; the conversion of cortexolone to hydrocortisone, and the corresponding control sequences effective in said host.
信息查询